| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.49B | +4.8% |
| Cost of Revenue | $197.3M | -1.7% |
| R&D Expense | $91.0M | +6.2% |
| SG&A Expense | $204.2M | +4.5% |
| Operating Income | $1.00B | +6.1% |
| Interest Expense | $75.3M | +0.0% |
| Pre-tax Income | $976.5M | +10.9% |
| Income Tax | $158.9M | -23.0% |
| Net Income | $817.6M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $240.1M | -35.7% |
| Short-term Investments | $686.3M | +13.1% |
| Accounts Receivable | $6.3M | +1.6% |
| Current Assets | $988.3M | -4.9% |
| Total Assets | $1.75B | +0.9% |
| Current Liabilities | $1.19B | +6.4% |
| Total Liabilities | $3.33B | +1.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $853.8M | +2.7% |
| Capital Expenditures | $45.8M | +67.2% |
| Investing Cash Flow | -$97.4M | -127.4% |
| Financing Cash Flow | -$889.8M | +14.1% |
| Free Cash Flow | $808.0M | +0.5% |
| +21.3% |
| Stockholders' Equity |
| -$1.58B |
| -1.2% |